Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement

Breakthrough invasive fungal infections (bIFI) cause significant morbidity and mortality. Their diagnosis can be challenging due to reduced sensitivity to conventional culture techniques, serologic tests, and PCR-based assays in patients undergoing antifungal therapy, and their diagnosis can be dela...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jeffrey D. Jenks, Jean-Pierre Gangneux, Ilan S. Schwartz, Ana Alastruey-Izquierdo, Katrien Lagrou, George R. Thompson III, Cornelia Lass-Flörl, Martin Hoenigl, European Confederation of Medical Mycology (ECMM) Council Investigators
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI AG 2020-10-01
Colección:Journal of Fungi
Materias:
breakthrough invasive fungal infections
invasive candidiasis
invasive mold infections
endemic mycoses
diagnostics
Acceso en línea:https://www.mdpi.com/2309-608X/6/4/216
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares